Rubin Eyal

Rubin Eyal is listed in filings as Sr. VP and CFO at Protalix BioTherapeutics, Inc.. This profile follows SEC Form 4 activity through Nov 5, 2024, including 2 public disclosures. Recent filings connect the profile to Protalix BioTherapeutics, Inc. (PLX). The current snapshot covers public activity from Sep 24, 2024 to Nov 5, 2024. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.